CSL PLASMA Trademark

Trademark Overview


On Tuesday, October 4, 2022, a trademark application was filed for CSL PLASMA with the United States Patent and Trademark Office. The USPTO has given the CSL PLASMA trademark a serial number of 97618260. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 29, 2024. This trademark is owned by CSL Limited. The CSL PLASMA trademark is filed in the Treatment & Processing of Materials Services, Advertising, Business and Retail Services, Insurance & Financial Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Education services, namely, providing classes, seminars, and workshops in the field of continuing medical education and health education; Education services, namely, providing classes, seminars, and workshops in the field of blood plasma, donation of blood plasma and blood plasma conditions; Educational services, namely, providing online instruction in the field of health, medicine, pharmaceuticals and medical treatment via an online website; Educational services, namely, providing online instruction in the field of blood plasma and blood plasma conditions via an online website; Non-downloadable electronic publications, namely, newsletters in the field of health, medicine, pharmaceuticals and treatment; Non-downloadable electronic publications, namely, newsletters in the field of blood plasma and blood plasma conditions

Treatment of biological products, namely, custom manufacturing and fractionation of blood; Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma

Insurance information and consultancy; charitable services, namely, providing financial support and financial information to patients and caregivers for obtaining medications, medical treatment, and access to care; Providing insurance information for patients diagnosed with medical conditions regarding medication access and reimbursement programs and insurance premium and co-pay assistance; providing insurance consulting services to patients diagnosed with medical conditions regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; providing financial assistance programs to appropriate patients

Promoting public awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines and related illnesses; Promoting public awareness of blood plasma donation; Promoting the donation of blood and volunteer services and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs; Providing information regarding medical billing support services, namely, medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance

Medical Research; Scientific Research in the field of medicines; Scientific Research and Development in the field of medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapy; Scientific Research in the field of blood plasma and blood plasma donation; Research and Development services in the fields of medicine, healthcare, blood conditions, gene and cell therapy, biotherapies and vaccines; Scientific and technological research, namely, scientific testing and screening services, in the nature of testing of human blood plasma for safety and quality; research and development of medical products, pharmaceutical products and blood products; new product research and development services; Laboratory analysis, namely, medical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals and blood plasma; scientific testing and screening services,...
csl plasma

General Information


Serial Number97618260
Word MarkCSL PLASMA
Filing DateTuesday, October 4, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2024

Trademark Statements


Goods and ServicesEducation services, namely, providing classes, seminars, and workshops in the field of continuing medical education and health education; Education services, namely, providing classes, seminars, and workshops in the field of blood plasma, donation of blood plasma and blood plasma conditions; Educational services, namely, providing online instruction in the field of health, medicine, pharmaceuticals and medical treatment via an online website; Educational services, namely, providing online instruction in the field of blood plasma and blood plasma conditions via an online website; Non-downloadable electronic publications, namely, newsletters in the field of health, medicine, pharmaceuticals and treatment; Non-downloadable electronic publications, namely, newsletters in the field of blood plasma and blood plasma conditions
Goods and ServicesTreatment of biological products, namely, custom manufacturing and fractionation of blood; Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma
Goods and ServicesInsurance information and consultancy; charitable services, namely, providing financial support and financial information to patients and caregivers for obtaining medications, medical treatment, and access to care; Providing insurance information for patients diagnosed with medical conditions regarding medication access and reimbursement programs and insurance premium and co-pay assistance; providing insurance consulting services to patients diagnosed with medical conditions regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; providing financial assistance programs to appropriate patients
Goods and ServicesPromoting public awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines and related illnesses; Promoting public awareness of blood plasma donation; Promoting the donation of blood and volunteer services and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs; Providing information regarding medical billing support services, namely, medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance
NOT AVAILABLE"PLASMA"
Goods and ServicesMedical Research; Scientific Research in the field of medicines; Scientific Research and Development in the field of medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapy; Scientific Research in the field of blood plasma and blood plasma donation; Research and Development services in the fields of medicine, healthcare, blood conditions, gene and cell therapy, biotherapies and vaccines; Scientific and technological research, namely, scientific testing and screening services, in the nature of testing of human blood plasma for safety and quality; research and development of medical products, pharmaceutical products and blood products; new product research and development services; Laboratory analysis, namely, medical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals and blood plasma; scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Providing medical and scientific research information in the field of pharmaceuticals and blood plasma; Providing scientific information in the field of health care developments, blood plasma conditions, and new medical therapies; scientific information services in the field of health care developments, blood plasma conditions, and new medical therapies provided via the Internet; providing research information on donation of human blood for medical research

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, October 20, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 20, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 20, 2022
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, October 20, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 20, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParkville, Victoria 3052
AU

Party NameCSL Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParkville, Victoria 3052
AU

Trademark Events


Event DateEvent Description
Friday, October 7, 2022NEW APPLICATION ENTERED
Thursday, October 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 19, 2023ASSIGNED TO EXAMINER
Wednesday, July 26, 2023NON-FINAL ACTION WRITTEN
Wednesday, July 26, 2023NON-FINAL ACTION E-MAILED
Wednesday, July 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 28, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 28, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, November 28, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 28, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, November 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2024SOU EXTENSION 1 GRANTED
Monday, July 29, 2024SOU EXTENSION 1 FILED
Tuesday, February 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT